New Delhi, February 27 Drug maker Abbott announced on Friday that it has partnered with Novo Nordisk India to commercialize Extensior, a second brand of Ozempic, for the treatment of type 2 diabetes in the country.The partnership leverages Novo Nordisk's scientific leadership in GLP-1s and...